Edmond de Rothschild (Suisse)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$3.52M Sell
109,408
-17,154
-14% -$574K 1.08% 18
2016
Q2
$4.23M Buy
126,562
+19,924
+19% +$636K 1.4% 17
2016
Q1
$3M Sell
106,638
-4,290
-4% -$123K 1.24% 18
2015
Q4
$3.4M Buy
110,928
+4,778
+5% +$150K 1.29% 16
2015
Q3
$3.16M Sell
106,150
-19,046
-15% -$611K 1.07% 21
2015
Q2
$3.98M Buy
+125,196
New +$4.08M 1.26% 17

Other funds holding PFE

Edmond de Rothschild (Suisse)'s PFE Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) reduced its Pfizer (PFE) stake by 14% in Q3 2016, selling an estimated $574K and leaving 109,408 shares worth $3.52M. The position accounts for 1.08% of the portfolio, ranked #18.

Edmond de Rothschild (Suisse) first reported a position in PFE in Q2 2015 and has held it in 6 quarters since. The position peaked at $4.23M in Q2 2016. 1,963 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

  • Edmond de Rothschild (Suisse) held 109,408 shares of Pfizer worth $3.52M as of Q3 2016.
  • Edmond de Rothschild (Suisse) sold 17,154 Pfizer shares in Q3 2016, an estimated $574K.
  • Pfizer made up 1.08% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #18 holding.
  • Edmond de Rothschild (Suisse) first reported a position in Pfizer in Q2 2015 and has held it in 6 quarters since.
  • Edmond de Rothschild (Suisse)'s Pfizer position peaked at $4.23M in Q2 2016.
  • 1,963 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.